Cargando…
Building the What Comes Next Cohort for BRCA1 and BRCA2 testing: a descriptive analysis
BACKGROUND: Our understanding of how testing for and mutations of the BRCA1 and BRCA2 genes affect cancer risk and the use of risk-reduction strategies comes largely from studies of women recruited from specialized genetics clinics. Our aim was to assemble a generalizable cohort of women who underwe...
Autores principales: | Dossa, Fahima, Metcalfe, Kelly, Sutradhar, Rinku, Little, Tari, Eisen, Andrea, Chun, Kathy, Meschino, Wendy S., Velsher, Lea, Ellis, Jordan Lerner, Baxter, Nancy N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Joule Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741196/ https://www.ncbi.nlm.nih.gov/pubmed/34870614 http://dx.doi.org/10.9778/cmajo.20200228 |
Ejemplares similares
-
Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol
por: Dossa, Fahima, et al.
Publicado: (2018) -
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation
por: Metcalfe, Kelly, et al.
Publicado: (2019) -
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011) -
BRCA mutated pancreatic cancer: A change is coming
por: Rosen, Michael N, et al.
Publicado: (2021) -
Oestrogen receptor status and survival in women with BRCA2-associated breast cancer
por: Metcalfe, Kelly, et al.
Publicado: (2019)